• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常染色体显性多囊肾病急性心肌梗死的临床表现、治疗与预后

Clinical Manifestation, Management and Prognosis of Acute Myocardial Infarction in Autosomal Dominant Polycystic Kidney Disease.

作者信息

Yang Bo, Wang Qi, Wang Rui, Xu Tao

机构信息

Department of Urology, Peking University People's Hospital, Beijing, China.

Department of Urology, Peking University People's Hospital, Beijing, China,

出版信息

Kidney Blood Press Res. 2018;43(6):1806-1812. doi: 10.1159/000495638. Epub 2018 Nov 30.

DOI:10.1159/000495638
PMID:30504716
Abstract

BACKGROUND/AIMS: Cardiovascular complications are the most common cause of death in individuals with autosomal dominant polycystic kidney disease (ADPKD), yet there is no substantial data concerning the clinical characteristics of acute myocardial infarction (AMI) in this population. This study thus aimed to investigate AMI in persons with ADPKD.

METHODS

A retrospective analysis of ADPKD patients admitted to our hospital over a 13 year period was conducted. Age and gender-matched control patients without ADPKD were also selected at a ratio of 1: 10.

RESULTS

A total of 52 ADPKD and 520 non-ADPKD patients were enrolled in the present study, with those in the former group exhibiting significantly poorer kidney function. The distribution of AMI types differed significantly between these two groups. The incidence of ST-segment elevation myocardial infarction (STEMI) was higher (75.0%) and the incidence of non-ST segment elevation myocardial infarction (NSTEMI) was lower (25.0%) in the ADPKD group. At the onset of AMI, sudden cardiac death (SCD) was more common in ADPKD patients (11.5% vs. 4.6%). In terms of risk factors, the occurrence of hypertension was greater in ADPKD patients (78.8% vs. 39.6%). With regard to subsequent management, ADPKD patients had a higher prevalence of triple-branch coronary lesions (21.1% vs. 11.2%), undergoing more coronary artery bypass grafting (CABG) (7.7% vs. 5.4%) and fewer percutaneous coronary interventions (PCI) (73.1% vs. 84.6%). Overall, ADPKD patients had higher rates of mortality (13.5% vs. 6.2%).

CONCLUSION

ADPKD patients with AMI suffer from more severe conditions and difficult therapies, resulting in a poorer prognosis.

摘要

背景/目的:心血管并发症是常染色体显性多囊肾病(ADPKD)患者最常见的死亡原因,但关于该人群急性心肌梗死(AMI)的临床特征尚无大量数据。因此,本研究旨在调查ADPKD患者中的AMI情况。

方法

对我院13年间收治的ADPKD患者进行回顾性分析。还按1:10的比例选取了年龄和性别匹配的无ADPKD的对照患者。

结果

本研究共纳入52例ADPKD患者和520例非ADPKD患者,前一组患者的肾功能明显较差。这两组之间AMI类型的分布有显著差异。ADPKD组中ST段抬高型心肌梗死(STEMI)的发生率较高(75.0%),非ST段抬高型心肌梗死(NSTEMI)的发生率较低(25.0%)。在AMI发作时,ADPKD患者中心脏性猝死(SCD)更为常见(11.5%对4.6%)。在危险因素方面,ADPKD患者中高血压的发生率更高(78.8%对39.6%)。在后续治疗方面,ADPKD患者三支冠状动脉病变的患病率更高(21.1%对11.2%),接受冠状动脉旁路移植术(CABG)的比例更高(7.7%对5.4%),接受经皮冠状动脉介入治疗(PCI)的比例更低(73.1%对84.6%)。总体而言,ADPKD患者的死亡率更高(13.5%对6.2%)。

结论

患有AMI的ADPKD患者病情更严重,治疗困难,预后较差。

相似文献

1
Clinical Manifestation, Management and Prognosis of Acute Myocardial Infarction in Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病急性心肌梗死的临床表现、治疗与预后
Kidney Blood Press Res. 2018;43(6):1806-1812. doi: 10.1159/000495638. Epub 2018 Nov 30.
2
An association between autosomal-dominant polycystic kidney disease and the risk of acute myocardial infarction in Asian population - results of a nationwide study.亚洲人群中常染色体显性多囊肾病与急性心肌梗死风险的关联——一项全国性研究的结果
Oncotarget. 2017 Mar 21;8(12):19365-19375. doi: 10.18632/oncotarget.14269.
3
Temporal trends in acute myocardial infarction: What about survival of hospital survivors? Disparities between STEMI & NSTEMI remain. Soroka acute myocardial infarction II (SAMI-II) project.急性心肌梗死的时间趋势:医院幸存者的生存情况如何?ST段抬高型心肌梗死与非ST段抬高型心肌梗死之间的差异依然存在。索罗卡急性心肌梗死II(SAMI-II)项目。
Int J Cardiol. 2016 Jan 15;203:1073-81. doi: 10.1016/j.ijcard.2015.11.072. Epub 2015 Nov 10.
4
Arterial stiffness may predict renal and cardiovascular prognosis in autosomal-dominant polycystic kidney disease.动脉僵硬度可能预测常染色体显性多囊肾病的肾脏和心血管预后。
Physiol Int. 2018 Jun 1;105(2):145-156. doi: 10.1556/2060.105.2018.2.17.
5
Long-Term Outcomes in Survivors of Early Ventricular Arrhythmias After Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention.经皮冠状动脉介入治疗的急性ST段抬高型和非ST段抬高型心肌梗死后早期室性心律失常幸存者的长期预后
Am J Cardiol. 2016 Mar 1;117(5):709-13. doi: 10.1016/j.amjcard.2015.12.002. Epub 2015 Dec 13.
6
Early Markers of Cardiovascular Risk in Autosomal Dominant Polycystic Kidney Disease.常染色体显性遗传多囊肾病的心血管风险早期标志物。
Kidney Blood Press Res. 2017;42(6):1290-1302. doi: 10.1159/000486011. Epub 2017 Dec 15.
7
Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.东京都地区ST段抬高型和非ST段抬高型心肌梗死的当前特征与管理:来自东京CCU网络注册队列研究
Heart Vessels. 2016 Nov;31(11):1740-1751. doi: 10.1007/s00380-015-0791-9. Epub 2016 Jan 12.
8
Impact of low level of high-density lipoprotein-cholesterol sampled in overnight fasting state on the clinical outcomes in patients with acute myocardial infarction (difference between ST-segment and non-ST-segment-elevation myocardial infarction).空腹状态下采集的低水平高密度脂蛋白胆固醇对急性心肌梗死患者临床结局的影响(ST段抬高型与非ST段抬高型心肌梗死之间的差异)
J Cardiol. 2015 Jan;65(1):63-70. doi: 10.1016/j.jjcc.2014.04.002. Epub 2014 Sep 18.
9
Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease.常染色体显性遗传多囊肾病继发慢性肾脏病患者的心血管危险因素及其对预后的影响。
BMC Nephrol. 2021 Mar 25;22(1):110. doi: 10.1186/s12882-021-02313-1.
10
Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease.血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂作为常染色体显性多囊肾病一线治疗的成本效益
J Med Econ. 2017 Jul;20(7):715-722. doi: 10.1080/13696998.2017.1311266. Epub 2017 Apr 13.

引用本文的文献

1
Cardiovascular Manifestations and Management in ADPKD.常染色体显性多囊肾病的心血管表现与管理
Kidney Int Rep. 2023 Aug 4;8(10):1924-1940. doi: 10.1016/j.ekir.2023.07.017. eCollection 2023 Oct.
2
A Systematic Review of Reported Outcomes in ADPKD Studies.常染色体显性多囊肾病(ADPKD)研究中报告结果的系统评价
Kidney Int Rep. 2022 Jul 5;7(9):1964-1979. doi: 10.1016/j.ekir.2022.06.012. eCollection 2022 Sep.
3
Arrhythmogenic Hearts in PKD2 Mutant Mice Are Characterized by Cardiac Fibrosis, Systolic, and Diastolic Dysfunctions.
多囊肾病2型(PKD2)突变小鼠的致心律失常心脏具有心脏纤维化、收缩和舒张功能障碍的特征。
Front Cardiovasc Med. 2021 Nov 26;8:772961. doi: 10.3389/fcvm.2021.772961. eCollection 2021.
4
Novel non-cystic features of polycystic kidney disease: having new eyes or seeking new landscapes.多囊肾病的新型非囊性特征:拥有新视角或探寻新景象。
Clin Kidney J. 2020 Sep 7;14(3):746-755. doi: 10.1093/ckj/sfaa138. eCollection 2021 Mar.
5
Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease.常染色体显性遗传多囊肾病继发慢性肾脏病患者的心血管危险因素及其对预后的影响。
BMC Nephrol. 2021 Mar 25;22(1):110. doi: 10.1186/s12882-021-02313-1.
6
Polycystins, ADPKD, and Cardiovascular Disease.多囊蛋白、常染色体显性多囊肾病与心血管疾病
Kidney Int Rep. 2019 Dec 21;5(4):396-406. doi: 10.1016/j.ekir.2019.12.007. eCollection 2020 Apr.